Bank Of Montreal Vincerx Pharma, Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$0.9 - $1.51 $11,160 - $18,724	12,400 New	12,400 $12,000
Q4 2022 Feb 01, 2023	BUY	$0.64 - $1.32 $7,935 - $16,366	12,399 New	12,399 $12,000
Q2 2022 Aug 11, 2022	SELL	$0.0 - $0.0 $0 - $0	-84,131 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.0 - $0.0 $0 - $0	84,131 New	84,131 $332,000
Q3 2021 Nov 12, 2021	SELL	$0.0 - $0.0 $0 - $0	-252,902 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$0.0 - $27.0 $0 - $6.83 Million	252,902 New	252,902 $3.18 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.